Brief: Nightingale Health Attains UKCA Marking For Its Blood Analysis Technology
20/08/2024 08:19
Aug 20 (Reuters) - Nightingale Health Oyj HEALTH.HE :
* NIGHTINGALE HEALTH ATTAINS UKCA MARKING FOR ITS BLOOD
ANALYSIS
TECHNOLOGY TO BRING ITS TECHNOLOGY TO HEALTHCARE USE IN THE
UNITED KINGDOM
Source text for Eikon: ID:nWkr1hFKPS
Further company coverage: HEALTH.HE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))
Recent news on Nightingale Health Oyj
See all newsBrief: Nightingale And The Private GP Group Enter Agreement
Brief: Siun Sote To Pilot Nightingale Health Risk Detection
Brief: Nightingale Enters Into Service Agreement In Latvia
Brief: Nightingale Health And Archipelago Health Sign Deal In Carribean, Bermuda
Finland's Nightingale Health annual revenue rises on expansion of commercial team